Evaluation of inflammatory change and bone erosion using a murine type II collagen-induced arthritis model

2010 ◽  
Vol 31 (5) ◽  
pp. 595-603 ◽  
Author(s):  
Samjin Choi ◽  
Yeon-Ah Lee ◽  
Seung-Jae Hong ◽  
Gi-Ja Lee ◽  
Sung Wook Kang ◽  
...  
Keyword(s):  
Bone Erosion ◽  
Type Ii Collagen ◽  
Inflammatory Change ◽  
Type Ii ◽  
Collagen Induced Arthritis ◽  
Arthritis Model

scholarly journals Genetic Control of Tolerance to Type II Collagen and Development of Arthritis in an Autologous Collagen-Induced Arthritis Model

2003 ◽  
Vol 171 (7) ◽  
pp. 3493-3499 ◽  
Author(s):  
Johan Bäcklund ◽  
Kutty Selva Nandakumar ◽  
Robert Bockermann ◽  
Lucia Mori ◽  
Rikard Holmdahl
Keyword(s):  
Genetic Control ◽  
Type Ii Collagen ◽  
Type Ii ◽  
Collagen Induced Arthritis ◽  
Arthritis Model

The natural soluble form of IL-18 receptor β exacerbates collagen-induced arthritis via modulation of T-cell immune responses

2009 ◽  
Vol 69 (01) ◽  
pp. 276-283 ◽  
Author(s):  
S Veenbergen ◽  
R L Smeets ◽  
M B Bennink ◽  
O J Arntz ◽  
L A B Joosten ◽  
...  
Keyword(s):  
T Cells ◽  
Immune Responses ◽  
Bone Erosion ◽  
Biological Activities ◽  
Type Ii Collagen ◽  
Histological Evaluation ◽  
Soluble Form ◽  
Type Ii ◽  
Collagen Induced Arthritis ◽  
Bovine Collagen

Objective:IL-18 is a pluripotent cytokine that has been implicated in the development of rheumatoid arthritis. A soluble form of the IL-18 receptor accessory protein (sIL-18Rβ) with unknown function has recently been identified. This study examined the ability of sIL-18Rβ to inhibit IL-18 biological activities and to modulate immune responses during collagen-induced arthritis (CIA).Methods:Adenoviruses encoding sIL-18Rβ were administered intravenously in type II collagen-immunised DBA/1 mice. Humoral responses were analysed by determining anti-bovine collagen type II (BCII) antibody levels by ELISA. Cytokine production by splenic T cells and cytokine levels in serum were measured by Luminex multi-analyte technology. CD4+CD25+Foxp3+ regulatory T cells (Treg) were measured by flow cytometry.Results:Intravenous delivery of Ad5.sIL-18Rβ in collagen-immunised mice led to enhanced transgene expression in splenic antigen-presenting cells (APC). A co-culture of these sIL-18Rβ-transduced APC with purified splenic CD3+ T cells led to a marked inhibition of IL-18-induced IFNγ, IL-4 and IL-17 production by CD3+ T cells. Remarkably, systemic treatment with Ad5.sIL-18Rβ caused an exacerbation of arthritis, and histological evaluation of knee joints showed increased cartilage and bone erosion. No significant differences were observed in anti-BCII antibodies, but the aggravation was accompanied by decreased IFNγ (−30%) and IL-4 (−44%) and increased IL-17 (+84%) production by splenic CD3+ T cells. In addition, reduced circulating levels of CD4+CD25+Foxp3+ Treg and anti-inflammatory IL-10 were shown.Conclusion:This study identifies sIL-18Rβ as a novel IL-18 inhibitor, which promotes CIA after intravenous overexpression by affecting Treg levels and supporting a T helper type 17 response.

scholarly journals Combination effect of Bucillamine and Methotrexate on rat type II collagen-induced arthritis model

2007 ◽  
Vol 27 (5) ◽  
pp. 516-521 ◽  
Author(s):  
Noriko Odani-Kawabata ◽  
Yoshiko Mukai ◽  
Fumio Tsuji ◽  
Hiroyuki Aono ◽  
Masahiro Okamoto ◽  
...  
Keyword(s):  
Type Ii Collagen ◽  
Combination Effect ◽  
Type Ii ◽  
Collagen Induced Arthritis ◽  
Arthritis Model

Combined effects of bucillamine and etanercept on a rat type II collagen-induced arthritis model

2010 ◽  
Vol 20 (4) ◽  
pp. 381-388 ◽  
Author(s):  
Chikako Setoguchi ◽  
Fumio Tsuji ◽  
Osamu Katsuta ◽  
Masahiro Okamoto ◽  
Hiroyuki Aono
Keyword(s):  
Type Ii Collagen ◽  
Combined Effects ◽  
Type Ii ◽  
Collagen Induced Arthritis ◽  
Arthritis Model

The Effect of Da-Fang-Feng-Tang on Treatment of Type II Collagen-induced Arthritis in DBA/1 Mice

1999 ◽  
Vol 27 (02) ◽  
pp. 205-215 ◽  
Author(s):  
Lian Rong Wang ◽  
Naoki Ishiguro ◽  
Eiji Yamada ◽  
Yoshihiro Nishida ◽  
Koji Sato ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Histological Examination ◽  
Bone Erosion ◽  
Type Ii Collagen ◽  
Treated Group ◽  
Control Group ◽  
Human Rheumatoid Arthritis ◽  
Type Ii ◽  
Collagen Induced Arthritis ◽  
Igg Antibody

Da-Fang-Feng-Tang (DFFr), which is believed to be effective for treating human rheumatoid arthritis (RA), was given to DBA/1 mice at the onset of type II collagen-induced arthritis (CIA) to examine its effect. Granules of the crude DFFT extract were administered by gastric gavage at a dose of 1.6 g/kg/day for 12 weeks, starting the day CIA began. The levels of anticollagen IgG antibody were significantly decreased in the sera of the DFFT-treated group compared with the control group from weeks 2 to 7 after the onset of CIA. The severity of arthritis in the DFFT-treated group was markedly alleviated when compared with the control group. In addition, histological examination of the DFFT-treated group showed less cartilage and bone erosion. These results suggest that administration of DFFT suppressed the development of CIA in mice and support the belief that DFFT is effective in treating human RA.

Effect of a novel anti-rheumatic drug, TA-383, on type II collagen-induced arthritis

1995 ◽  
Vol 17 (7) ◽  
pp. 597-603 ◽  
Author(s):  
Makoto Ueno ◽  
Kazunori Imaizumi ◽  
Takahisa Sugita ◽  
Isao Takata ◽  
Masakazu Takeshita
Keyword(s):  
Type Ii Collagen ◽  
Type Ii ◽  
Collagen Induced Arthritis ◽  
Rheumatic Drug

scholarly journals Dexamethasone Preconditioning Improves the Response of Collagen-Induced Arthritis to Treatment with Short-Term Lipopolysaccharide-Stimulated Collagen-Loaded Dendritic Cells

2013 ◽  
Vol 2013 ◽  
pp. 1-7 ◽  
Author(s):  
Corina Peña ◽  
David Gárate ◽  
Juan Contreras-Levicoy ◽  
Octavio Aravena ◽  
Diego Catalán ◽  
...  
Keyword(s):  
T Cells ◽  
Dendritic Cells ◽  
Cd4 T Cells ◽  
Combined Treatment ◽  
Type Ii Collagen ◽  
Cytokine Profile ◽  
Clinical Disease ◽  
Type Ii ◽  
Collagen Induced Arthritis ◽  
Short Term

Background. Pharmacologically modulated dendritic cells (DCs) have been shown to restore tolerance in type II collagen-(CII-) induced arthritis (CIA). We examined the effect of dexamethasone (DXM) administration as a preconditioning agent, followed by an injection of lipopolysaccharide-(LPS-) stimulated and CII-loaded DCs on the CIA course.Methods. After CIA induction, mice pretreated with DXM were injected with 4-hour LPS-stimulated DCs loaded with CII (DXM/4hLPS/CII/DCs).Results. Mice injected with DXM/4hLPS/CII/DCs displayed significantly less severe clinical disease compared to animals receiving 4hLPS/CII/DCs alone or those in which only DXM was administered. Cytokine profile evaluation showed that CD4+ T cells from DXM/4hLPS/CII/DCs and 4hLPS/CII/DCs groups release higher IL-10 levels than those from mice receiving DXM alone or CIA mice. CD4+ T cells from all DC-treated groups showed less IL-17 release when compared to the CIA group. On the contrary, CD4+ T cells from DXM/4hLPS/CII/DCs and 4hLPS/CII/DCs groups released higher IFN-γlevels than those from CIA group.Conclusion. A combined treatment, including DXM preconditioning followed by an inoculation of short-term LPS-stimulated CII-loaded DCs, provides an improved strategy for attenuating CIA severity. Our results suggest that this benefit is driven by a modulation in the cytokine profile secreted by CD4+ T cells.

Sign in / Sign up

Export Citation Format

Share Document